The role and regulation of FOXO3a in cancer and chemotherapy resistance
Drug resistance is the major impediment to the success of cancer therapy. The PI3K/AKT pathway mediates a plethora of cellular functions, including cell survival, proliferation and differentiation. However, increased activation of this pathway has been correlated with drug resistance mechanisms. Thi...
Main Author: | Gomes, Ana Rita |
---|---|
Other Authors: | Lam, Eric |
Published: |
Imperial College London
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.616712 |
Similar Items
-
FOXO3a and ID1 as targets of chemotherapy in breast cancer
by: McGovern, Ursula Brigid
Published: (2009) -
The identification of novel genes involved in chemotherapy resistance in ovarian cancer
by: Gilmore, Paula
Published: (1997) -
Dose intensive chemotherapy in ovarian cancer and the role of stem cell factor
by: Weaver, Andrew
Published: (1998) -
Proteomic identification of putative biomarkers of neo-adjuvant chemotherapy resistance in luminal (ER+) breast cancer
by: Hussain, Tasadooq
Published: (2013) -
The Emerging Roles of circFOXO3 in Cancer
by: Dean Rao, et al.
Published: (2021-06-01)